Through the AWS Diagnostic Development initiative, research institutions and private companies using the cloud platform to support their coronavirus-related research workloads will be eligible to receive AWS credits and technical support to advance their work.
The initiative launched with participation from 35 research institutions, startups and businesses around the world. Though the initial focus is on developing diagnostic tools to prevent and treat COVID-19, it may be expended to include other infectious diseases in the future.
“The world needs more and more private sector innovation to combat this pandemic. Amazon’s commitments and participation are very welcome, particularly since the lack of significant next-generation diagnostic tools remains a large gap in most health systems. A platform to link research, digital capabilities and new products to customers globally is an exciting venture,” Steve Davis, a member of the World Health Organization’s Digital Health Technical Advisory Group and of the AWS initiative’s technical advisory group, said in the announcement.
More articles on health IT:
‘#GetMePPE’: Clinicians turn to social media to plead for masks, gowns
Nevada health department adds data dashboard to COVID-19 information center
As employees turn remote, employers must up cybersecurity efforts
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.